Equities
Basic MaterialsChemicals
  • Price (EUR)121.85
  • Today's Change-0.05 / -0.04%
  • Shares traded134.15k
  • 1 Year change14.95%
  • Beta0.9233
Data delayed at least 15 minutes, as of Jun 26 2019 11:07 BST.
More ▼

Profile data is unavailable for this security.

About the company

L'Air Liquide S.A. (Air Liquide) is a France-based company engaged in providing gases, technologies and services for industry and health with a presence in over 80 countries. The Company's segments include Gas & Services, Engineering & Construction, and Global Markets & Technologies. The Gas & Services activity is organized into four geographic regions: Europe, Americas, Asia-Pacific, and Middle East and Africa. The Gas and Services segment includes four business lines, which include Large Industries, Industrial Merchant, Healthcare and Electronics. The Engineering & Construction segment designs, develops and builds industrial gas production plants for the Company and third parties. It also designs and manufactures plants in the traditional, renewable and alternative energy sectors. The Global Markets & Technologies segment comprises advanced Business & Technologies (aB&T) and Air Liquide Maritime. The Company operates through Skagerak Naturgass AS and Sogo Sangyo Kabushiki Kaisha.

  • Revenue in EUR (TTM)21.01bn
  • Net income in EUR2.11bn
  • Incorporated1955
  • Employees66.00k
  • Location
    Air Liquide75 Quai D Orsay, Paris Cedex 07PARIS 75321FranceFRA
  • Phone+33 140625555
  • Fax+33 140625526
  • Websitehttps://www.airliquide.com
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AI:PAR since
announced
Transaction
value
Medidis BVAnnounced13 Jun 201913 Jun 2019Announced3.00%--
Megamed AGDeal completed05 Feb 201905 Feb 2019Deal completed14.79%--
Sleep & Health SADeal completed05 Feb 201905 Feb 2019Deal completed14.79%--
Data delayed at least 15 minutes, as of Jun 26 2019 11:07 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Yara International ASA11.75bn125.80m11.24bn16.76k91.231.4513.500.97844.484.48417.62281.520.76933.967.416,804,743.000.68814.990.87986.2923.3525.450.89445.740.79062.170.333193.8813.82-2.24-66.67-30.497.70-15.06
Evonik Industries AG15.06bn917.00m11.51bn35.95k12.351.446.100.7521.971.9132.3316.940.71944.958.47417,945.204.494.495.545.4830.4431.106.255.911.1611.780.37165.644.463.4130.438.24-0.96012.83
Chr Hansen Holding A/S1.13bn239.61m13.19bn3.15k54.0516.7842.7811.4613.6013.6064.2843.810.60623.166.882,682,915.0012.8311.7115.4013.8555.5453.3921.1619.700.780815.320.520773.713.288.251.8810.618.7314.69
Akzo Nobel NV9.27bn354.00m18.64bn34.40k53.182.1328.282.021.5428.3340.3138.460.56944.474.00268,550.702.443.953.695.8542.3142.104.285.641.7514.780.239274.25-3.70-8.70-8.88-7.57-24.822.51
Koninklijke DSM N.V.9.12bn934.00m19.30bn21.44k20.292.3114.822.135.295.2951.6446.510.6632--4.97434,952.605.974.117.395.39--33.859.016.311.6810.700.258140.507.360.9069-40.1521.011.326.87
Sika AG6.39bn615.93m20.17bn20.06k35.0015.9725.303.184.544.5447.099.961.164.365.64353,210.4011.2910.7214.6813.8052.9553.929.709.321.6940.080.642243.4613.406.626.1214.829.1716.62
Givaudan S.A.4.98bn597.98m23.03bn13.60k38.916.9028.014.6471.3471.34594.84402.310.66683.204.61406,456.808.009.379.6911.2542.1444.7712.0013.371.5011.510.467679.849.424.81-7.926.2310.815.01
Henkel AG & Co KGaA20.03bn2.30bn36.58bn53.00k16.862.1612.741.865.255.2545.6540.900.65994.785.14377,981.107.658.5410.9111.8646.2047.4811.5911.370.776955.100.191833.50-0.64914.00-8.267.7813.938.68
Air Liquide SA21.01bn2.11bn50.82bn66.00k24.092.8612.852.434.934.9349.0041.550.50625.927.78318,350.005.315.726.527.0460.6161.8510.4910.990.713911.370.436954.073.256.65-5.525.200.84915.24
Data as of Jun 26 2019. Currency figures normalised to Air Liquide's reporting currency: Euro EUR

Institutional shareholders

10.42%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 May 201911.60m2.70%
BlackRock Fund Advisorsas of 06 Jun 20196.06m1.41%
Amundi Asset Management SA (Investment Management)as of 04 Jun 20194.24m0.99%
Lyxor International Asset Management SASas of 19 Jun 20193.87m0.90%
Norges Bank Investment Managementas of 31 Dec 20183.65m0.85%
Mawer Investment Management Ltd.as of 31 Dec 20183.59m0.84%
Massachusetts Financial Services Co.as of 30 Apr 20193.09m0.72%
BNP Paribas Asset Management France SASas of 06 Jun 20192.96m0.69%
BlackRock Advisors (UK) Ltd.as of 06 Jun 20192.86m0.67%
Artisan Partners LPas of 31 Mar 20192.84m0.66%
More ▼
Data from 31 Dec 2018 - 19 Jun 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.